Stock Updates

Today’s Top Gainers in the Market Edwards Lifesciences Corp. (NYSE:EW) from Healthcare

Today’s top gainers include the company Edwards Lifesciences Corp. (NYSE:EW) which is in the industry Medical Appliances & Equipment, gaining -1.15% today. In the last week its performance is 2.64%, and -6.19% for the past quarter. Currently, Edwards Lifesciences Corp., EW has a target price of 117.59, so today’s gain of -1.15% is a significant step towards its target price. The GAP today is therefore 0.10%.

Edwards Lifesciences Corp. (NYSE:EW), has a market cap of 21118.79, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 87.80%.

At the current price of 98.58, it has a dividend yield of *TBA, and its target price is 117.59. This is with a profit margin of 19.80%, and total debt/equity of 0.26. Edwards Lifesciences Corp. (NYSE:EW) has a P/E of 42, as well as a forward P/E of 29.99.

With a current EPS of 2.35, and a forecasted EPS growth for next year at 18.66%,Edwards Lifesciences Corp. (NYSE:EW) has had a EPS growth for the past five years at 19.70%. For the next five years EPS growth is projected to be 16.82%.

Performance for the year is 38.41%. Since its IPO date on 3/27/2000, the total performance to date is 24.82%.

Volume today for Edwards Lifesciences Corp. (NYSE:EW), is 1271297, while its average volume is 1852.84. Whilst the total gain today was -1.15%, it did have a day high of -11.98%.

Volatility for this week has been at 1.96%, and 1.85% for the month. The 52-week low for Edwards Lifesciences Corp., EW has been 57.65%, while the 52-week-high has reached -11.98%.

Looking at its return of investments, which is 15.90%, and its return on assets is 13.40%. Edwards Lifesciences Corp. (NYSE:EW) has an operating margin of 24.70%. With a sales growth of 18.10% quarter over quarter. Bearing in mind that Edwards Lifesciences Corp., EW is in the sector Healthcare, its long-term debt/equity is 0.26, and has a current ratio of 4 and 3.2 for quick ratio.

So what is the value of Edwards Lifesciences Corp.? Well its PEG is 2.5, and the P/S is 8.12, along with a P/B of 9.14. Meanwhile it has a p/cash of 22.19.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment